Study for LY3209590

Enroll Now

Type of Study:

An interventional randomized study to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes that have already been treated with basal insulin.

Title of Study:

Study of LY3209590

Short Title:


Study Length: 32 weeks

Target Age/Sex: over 18 years of age Male and Female


Participants will receive at no cost: study product, study materials and study-specific procedures


Live better, healthier, smarter

Schedule an Appointment